sever
acut
respiratori
syndrom
sar
caus
newli
emerg
coronaviru
infect
individu
result
fatal
current
effect
treatment
epidem
pro
shown
essenti
replic
thu
target
drug
discoveri
class
stabl
benzotriazol
ester
report
mechanismbas
inactiv
pro
potent
inactiv
exhibit
k
inact
k
nm
mechanist
investig
kinet
mass
spectrometri
analys
indic
activ
site
acyl
irrevers
inactiv
observ
use
mutant
addit
noncoval
competit
inhibit
becam
appar
use
benzotriazol
ester
surrog
bridg
esteroxygen
group
replac
carbon
sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
first
occur
guandong
affect
individu
across
countri
result
fatal
origin
sarscov
unclear
though
studi
molecular
evolut
sarscov
indic
viru
may
emerg
nonhuman
speci
present
efficaci
therapi
sar
avail
therefor
search
effect
antivir
sarscov
current
interest
sar
coronaviru
positivestrand
rna
viru
encod
two
polyprotein
proteolyt
process
provid
function
protein
viral
propag
process
mediat
primarili
main
proteas
pro
known
dimer
chymotrypsinlik
proteas
pro
activ
site
pro
contain
constitut
catalyt
dyad
cystein
thiol
function
nucleophil
proteolyt
process
due
essenti
role
viral
replic
proteas
attract
target
develop
therapeut
sar
far
inhibitor
pro
report
includ
hiv
proteas
inhibitor
zincconjug
compound
aryl
boron
acid
analog
quinolinecarboxyl
deriv
thiophenecarboxyl
phthalhydrazidesubstitut
ketoglutamin
analog
anilid
howev
none
inhibitor
exhibit
activ
low
nanomolar
rang
preclin
studi
report
part
effort
direct
toward
develop
potent
antisar
agent
report
discoveri
new
class
mechanismbas
irrevers
inactiv
inhibit
constant
nanomolar
rang
use
strategi
combinatori
reaction
microtit
plate
follow
screen
situ
approach
reli
use
highyield
organ
reaction
carri
water
watermisc
nontox
solvent
microscal
without
protect
group
allow
product
assay
directli
situ
without
isol
purif
use
approach
one
quickli
modifi
lead
compound
small
set
build
block
identifi
optim
inhibitor
previous
report
hiv
proteas
inhibitor
lopinavir
figur
also
inhibit
pro
ic
mm
order
find
potent
pro
inhibitor
librari
lopinavirlik
compound
assembl
use
either
diamin
amin
core
structur
reaction
variou
acid
microtit
plate
follow
screen
situ
figur
typic
procedur
librari
carboxyl
acid
see
supplement
data
avail
articl
onlin
mmol
microtit
plate
use
coupl
amin
mmol
presenc
n
ndiisopropylethylamin
mmol
hexafluorophosph
hbtu
mmol
dmf
ml
hr
aliquot
product
base
put
convers
start
materi
taken
subject
pro
inhibit
assay
mm
bistri
buffer
ph
obtain
ic
valu
initi
veloc
inhibit
reaction
nm
proteas
mm
fluorogen
substrat
plot
differ
inhibitor
concentr
studi
notic
product
deriv
acid
well
ic
mm
methylamino
benzoic
acid
well
ic
mm
dimethylamino
benzoic
acid
well
ic
mm
diethylamino
benzoic
acid
well
ic
mm
show
best
inhibit
degre
inhibit
independ
amin
use
order
character
inhibitor
attempt
separ
prepar
pure
amid
deriv
found
amid
format
slow
intermedi
benzotriazol
ester
isol
major
product
silica
gel
column
xray
ortep
structur
compound
shown
supplement
data
surpris
lopinavirlik
compound
show
modest
inhibitori
activ
toward
pro
ic
r
mm
wherea
benzotriazol
ester
show
high
inhibit
activ
knowledg
benzotriazol
ester
use
acyl
agent
never
found
enzym
inhibitor
prepar
seri
benzotriazol
ester
condens
hbtu
variou
carboxyl
acid
figur
found
benzotriazol
ester
deriv
benzoic
acid
contain
electronwithdraw
substitu
eg
cn
cf
suscept
hydrolysi
wherea
benzotriazol
ester
electrondon
group
rel
stabl
ph
hr
room
temperatur
rel
stabil
deriv
depend
pka
correspond
benzoic
acid
basic
follow
hammett
equat
stabl
benzotriazol
ester
ester
figur
assay
inhibit
result
pro
shown
tabl
studi
inhibit
benzotriazol
ester
show
timedepend
decreas
enzym
activ
function
inhibitor
concentr
eg
inhibit
compound
figur
presenc
mm
dtt
dithiothreitol
preincub
enzym
inhibitor
affect
enzym
activ
indic
dtt
protect
enzym
inactiv
figur
procedur
shown
supplement
data
use
initi
rate
inactiv
min
show
pseudo
firstord
kinet
determin
inhibit
constant
enzym
activ
howev
reduc
zero
time
period
perhap
decomposit
thioester
intermedi
exist
two
popul
enzym
shown
tabl
benzotriazol
ester
strong
inhibitor
among
potent
inactiv
constant
inhibit
constant
nm
addit
ester
toxic
vero
cell
often
use
cellbas
assay
sarscov
concentr
mm
compound
repres
potent
mechanismbas
pro
inhibitor
report
date
also
investig
natur
inhibit
enzym
mass
spectrometri
electrospray
ioniz
mass
spectra
wildtyp
pro
pro
treat
dimethylamino
benzoyl
ester
hr
incub
hr
dialysi
deconvolut
mass
spectra
determin
see
supplement
data
mass
differ
da
peak
h
h
impli
acyl
pro
dimethylamino
benzoyl
moieti
mass
investig
acyl
site
malditof
mass
spectrometr
analysi
trypsin
digest
pro
pro
treat
dimethylamino
benzoyl
ester
perform
maldi
spectra
tryptic
pro
tryptic
acyl
pro
peptid
fragment
mass
shift
da
da
acyl
da
indic
peptid
fragment
contain
acyl
residu
figur
order
determin
acyl
site
acyl
peptid
perform
sequenc
analysi
maldi
msm
peptid
acyl
depict
figur
mass
differ
among
seri
fragment
ion
mass
shift
da
da
versu
da
b
clearli
show
acyl
site
consist
observ
mass
shift
mutant
pro
treat
dimethylamino
benzoyl
ester
result
support
mechan
irrevers
inhibit
pro
dimethylamino
benzoyl
ester
via
acyl
figur
order
develop
stabl
noncoval
inhibitor
base
benzotriazol
ester
discov
studi
synthes
compound
use
tbafassist
nalkyl
addit
compound
hydrogen
pd
oh
c
catalyst
room
temperatur
obtain
compound
compound
methyl
dimethyl
compound
use
tbaf
reagent
figur
compound
featur
benzotriazol
ester
inhibitor
except
ester
oxygen
replac
carbon
inhibit
analysi
show
compound
noncoval
competit
inhibitor
albeit
rel
weak
one
compar
correspond
ester
compound
potent
k
mm
reduct
carbonyl
group
howev
result
signific
loss
activ
figur
note
benzotriazol
compound
contain
three
equilibrium
structur
solut
figur
compound
may
mimic
ester
form
instead
three
equilibrium
form
found
solut
gain
insight
mode
inhibit
dock
experi
base
comput
model
autodock
version
bind
compound
pro
carri
result
indic
benzotriazol
moieti
dispos
pocket
form
activ
site
figur
gs
atom
close
enough
within
rigid
model
carbonyl
group
benzotriazol
ester
render
nucleophil
attack
aminophenyl
group
indol
moieti
region
surround
nh
group
indol
moieti
hydrogen
bond
side
chain
oh
comparison
indol
group
lack
hydrogen
bond
thu
show
weaker
affin
toward
pro
isom
compound
fit
pocket
well
enough
interact
residu
mention
calcul
minim
energi
bind
kcalmol
higher
correspond
ester
consist
inhibit
assay
result
see
supplement
data
sever
acut
respiratori
syndrom
sar
newli
emerg
diseas
caus
novel
human
coronaviru
current
effect
antivir
agent
exist
deadli
epidem
main
proteas
sarscov
pro
attract
target
drug
discoveri
due
essenti
role
viral
replic
discov
sever
stabl
benzotriazol
ester
new
class
irrevers
enzym
inhibitor
knowledg
compound
potent
mechanismbas
pro
inhibitor
known
date
mode
action
studi
shown
proceed
acyl
activ
site
assist
catalyt
dyad
materi
method
sarscov
proteas
prepar
accord
previous
describ
procedur
reaction
requir
dri
condit
carri
inert
atmospher
use
standard
techniqu
reagent
solvent
reagent
grade
use
without
purif
unless
otherwis
specifi
thf
distil
sodium
benzophenon
ketyl
n
hrm
valu
obtain
use
ei
ioniz
sourc
solut
acid
compound
equiv
hexafluorophosph
hbtu
equiv
dmf
ml
well
n
ndiisopropylethylamin
diea
equiv
ad
solut
stir
hr
reaction
mixtur
ad
nahco
ml
extract
ethyl
acet
ea
ml
organ
layer
collect
concentr
reduc
pressur
residu
purifi
use
column
chromatographi
silica
gel
provid
desir
ester
standard
procedur
follow
use
acid
standard
procedur
follow
use
dimethylamino
benzoic
acid
standard
procedur
follow
use
benzoic
acid
mg
mmol
equiv
hbtu
mg
mmol
equiv
diea
ml
mmol
equiv
reaction
mixtur
work
residu
purifi
use
column
chromatographi
chloroform
eluant
benzotriazol
ester
mg
mmol
obtain
yield
white
solid
tlc
r
f
chcl
eluant
acid
ester
standard
procedur
follow
use
acid
mg
mmol
equiv
hbtu
mg
mmol
equiv
diea
ml
mmol
equiv
reaction
mixtur
work
residu
purifi
use
column
chromatographi
chloroform
eluant
benzotriazol
ester
mg
mmol
obtain
yield
lightyellow
solid
tlc
r
f
meoh
chcl
eluant
gener
procedur
tbafassist
benzotriazol
nalkyl
benzotriazol
mg
mmol
diethylamino
acetophenon
mg
mmol
equiv
place
ml
flask
stir
bar
follow
addit
tbaf
ml
mmol
equiv
thf
room
temperatur
stir
hr
room
temperatur
reaction
directli
load
column
product
elut
solut
hexan
ethyl
acet
yield
mg
product
paleyellow
solid
inhibit
assay
sarscov
proteas
fluorometr
assay
util
determin
inhibit
constant
prepar
sampl
briefli
fluorogen
peptid
dabcylktsavlqsgfrkmeedan
use
substrat
enhanc
fluoresc
due
cleavag
substrat
catalyz
proteas
monitor
nm
excit
nm
ic
valu
individu
inhibitor
measur
reaction
mixtur
contain
nm
sar
proteas
mm
fluorogen
substrat
mm
bistri
ph
enzym
stock
solut
kept
mm
trishcl
ph
contain
mm
nacl
mm
edta
plu
mm
bme
ad
assay
solut
k
measur
noncoval
inhibitor
case
perform
two
fix
inhibitor
concentr
variou
substrat
concentr
mechanismbas
inactiv
case
use
versu
inactiv
ki
measur
detail
procedur
behavior
inhibitor
pleas
see
supplement
data
express
purif
sarscov
pro
wildtyp
mutant
sar
proteas
clone
pet
ntermin
trx
tag
fxa
site
tag
remov
fxa
proteas
protein
purifi
ninta
column
chromatographi
detail
experiment
procedur
pleas
see
esim
experi
conduct
bruker
dalton
biotof
iii
highresolut
mass
spectromet
equip
homebuilt
nanoesi
sourc
mass
resolut
better
onepass
mode
mass
rang
sampl
dilut
mm
bidistil
aqueou
solut
contain
methanol
formic
acid
vvv
infus
syring
pump
flow
rate
nlmin
actual
amount
sampl
consum
less
fmole
maldim
measur
perform
malditof
tof
mass
spectromet
appli
biosystem
proteom
analyz
tryptic
digest
solut
mix
matrix
solut
chca
acid
mgml
solvent
h
och
cntfa
ml
spot
well
maldi
spectrum
accumul
laser
shot
random
sampl
posit
per
well
comput
model
sarscov
proteas
inhibit
dock
perform
use
autodock
version
precomput
energi
grid
map
grid
point
space
grid
point
center
activ
site
use
autogrid
tool
autodock
version
dock
experi
compound
kept
flexibl
except
ring
amid
bond
builtin
lga
method
adopt
compound
structur
energi
evalu
pose
select
gener
per
run
crystal
structur
sarscov
proteas
complex
substrateanalog
inhibitor
code
obtain
protein
data
bank
pdb
http
wwwrcsborgpdb
detail
procedur
pleas
see
supplement
data
supplement
data
includ
differ
acid
xray
data
compound
synthesi
character
compound
supplement
enzym
kinet
studi
detail
molecular
dock
data
avail
http
wwwchembiolcomcgi
